Markets:

Overview

News

Currencies

International

Treasuries

ImmunityBio, Inc. - Common Stock (NQ:IBRX)

2.105 -0.045 (-2.09%)

Streaming Delayed Price Updated: 11:24 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ImmunityBio, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. (IBRX) Investors

July 07, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Calling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!

July 07, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NATIONALLY RANKED ROSEN LAW FIRM Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX

July 06, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Calling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!

July 06, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER ACTION REMINDER: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against ImmunityBio, Inc. (NASDAQ: IBRX); Lead Plaintiff Deadline is August 29, 2023

July 06, 2023

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arrow and ImmunityBio and Encourages Investors to Contact the Firm

July 05, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ImmunityBio, Inc. (IBRX) on Behalf of Investors

July 05, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of ImmunityBio, Inc. (IBRX) on Behalf of Investors

July 05, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

IMMUNITYBIO, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. (NASDAQ: IBRX)

July 05, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – IBRX

July 03, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. and Encourages Investors to Contact the Firm

July 02, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against ImmunityBio, Inc. (IBRX)

June 30, 2023

From Robbins LLP

Via Business Wire

Oracle And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

June 13, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. SunCar Technology Group Inc. (NASDAQ: SDA) shares jumped 31.2% to $22.13...

Via Benzinga

7 High-Risk, High-Reward Stocks to Buy in June ↗

June 12, 2023

These are the best high-risk, high-reward stocks to buy in June. They can all generate big profits for investors.

Via InvestorPlace

Over $72M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

June 06, 2023

The Dow Jones closed lower by around 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

ImmunityBio to Participate in the Jefferies Global Healthcare Conference

May 22, 2023

From ImmunityBio, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 18, 2023

Via Benzinga

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 12, 2023

Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ImmunityBio, Inc. and Encourages Investors with Losses to Contact the Firm

May 12, 2023

From The Schall Law Firm

Via Business Wire

Nasdaq Turns Positive; Absolute Software Shares Spike Higher ↗

May 11, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Thursday. The Dow traded down 0.70% to 33,297.64 while the NASDAQ rose 0.31% to 12,344.45. The S&P 500,...

Via Benzinga

Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 11, 2023

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) gained 109.8% to $1.06 after reporting a rise in Q1 sales.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 11, 2023

Via Benzinga

Crude Oil Down Over 1%; Disney Shares Tumble Following Q2 Results ↗

May 11, 2023

U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 250 points on Thursday. The Dow traded down 0.81% to 33,258.20 while the NASDAQ fell 0.11% to 12,294.23. The S&P 500,...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ImmunityBio, Inc. and Encourages Investors with Losses to Contact the Firm

May 11, 2023

From The Schall Law Firm

Via Business Wire

JasmyCoin Price Predictions: Where Will the JASMY Crypto Go Next? ↗

May 11, 2023

JasmyCoin (JASMY) price predictions are a hot topic among crypto traders on Thursday as they wonder if the token will continue to fall.

Via InvestorPlace

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of ImmunityBio Inc. (IBRX) Investigation

May 11, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Why Is ImmunityBio (IBRX) Stock Down 54% Today? ↗

May 11, 2023

ImmunityBio (IBRX) stock is falling on Thursday after the company got a response letter from the FDA concerning its bladder cancer treatment.

Via InvestorPlace

Dow Drops 1%; US Producer Prices Rise In April ↗

May 11, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 1% on Thursday. Following the market opening Thursday, the Dow traded down 1.15% to 33,144.32 while the NASDAQ fell 0.17% to...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ImmunityBio, Inc. - Common Stock (NQ:IBRX)

All News about ImmunityBio, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today